Introduction {#S1}
============

Pregnancy in eutherian mammals represents a unique and fascinating immunological process in which paternal, semi-allogeneic, antigens carried by the fetus must to be "tolerated" by the maternal immune system ([@B1]). This requires a fine and highly regulated balance between immune activation, to ensure proper protection of the mother against pathogens, and immune tolerance that allows the survival of the semi-allogeneic fetuses within the maternal uterus. Minimal disturbances of this fine equilibrium may have deleterious effect not only in the progeny but also in the mother ([@B1]).

Paternal antigens, present in the semen, are being recognized by the maternal immune system even before the process of fecundation has taken place ([@B2], [@B3]). As pregnancy is established, embryo starts growing and the transfer of fetal cells, as well as cell debris into the maternal circulation increases ([@B4]). As for other antigens, paternal antigens can be up-taken by maternal professional antigen presenting cells (APCs), processed and presented to naïve T cell encouraging their differentiation into different T cell lineages, namely: Th1, Th2, Th17, or regulatory T cells depending on different signals ([@B2], [@B5]--[@B7]).

Pregnancy wellbeing was classically associated with a shift toward a Th2 profile while the prevalence of Th1 as well as Th17 cells is associated with different pregnancy-associated pathologies, e.g., miscarriages ([@B8], [@B9]), intrauterine growth restriction ([@B10]), pre-eclampsia ([@B11], [@B12]), and pre-term birth ([@B13], [@B14]).

Among professional APCs, peritoneal cavity (PerC) B-1a B cells have been shown to be potent inducers of Th1 ([@B15]) as well as Th17 T cell differentiation ([@B16]). However, under especial conditions, e.g., CD86 blockage, B-1a B cells fail to induce Th1/17 T cell polarization. Instead, they strongly boost the differentiation of naïve T cells into newly expressing FOXP3 inducible regulatory T cells (iTregs) ([@B15]).

We have previously demonstrated that B-1a B cells are involved in the humoral immune response associated with the physiopathology of pre-eclampsia, one of the leading causes of pregnancy complications ([@B17]). In this study we aimed to further investigate the capacity of B-1a B cells to regulate the differentiation of the pro-inflammatory Th17 and Th1 T cells subsets in a murine model of pregnancy disturbances.

Materials and Methods {#S2}
=====================

Animals and animal model of pregnancy disturbances {#S2-1}
--------------------------------------------------

Eight weeks old CBA/J (H2^k^) and C57BL/6 (H2^b^) females as well as BALB/c (H2^d^) and DBA/2J (H2^d^) males were purchased from Charles River (Germany/France). Mice were kept in our animal facility under optimal conditions in a 12-h light cycle. Chow and water were applied *ad libitum*. Animal experiments were carried out according to institutional guidelines after Ministerial approval \[Reviewing board institution: Landesverwaltungsamt Sachsen-Anhalt (ID: FJ2-101 to Federico Jensen) and Landensamt für landwirtschaft Lebensmittelsicherheit und Fischrei Mecklenburg-Vorpommer (7221.3-1-068/13 to Federico Jensen)\]. The experiments were conducted in conformity with the European Communities Council Directive.

A well-established model of pregnancy disturbances was used ([@B18]). Briefly, when CBA/J females are mated to DBA/2J males, a median of 20--30% of the embryos resorption (abortions) is observed ([@B19]). Besides, pregnant females from this combination are also characterized by angiogenic deregulation, abnormal placental development, and fetal growth restriction, all features of pre-eclampsia ([@B20]). BALB/c mated CBA/J females represent the normal pregnancy combination with a median of 0% of abortions and none of the symptoms described above for the DBA/2J mated CBA/J females.

Virgin females CBA/J mice were mated with BALB/c, or DBA/2J males. Females were inspected daily for vaginal plugs, and presence of a vaginal plug was designated as day 0 of pregnancy. Pregnant females were sacrificed at day 14 of pregnancy.

Antibodies and reagents {#S2-2}
-----------------------

The following anti-mouse fluorescently labeled antibodies were used: CD19 (clone 1D3), CD11b (clone M1/70), CD5 (clone 53-7.3), CD80 (clone 16-1OA1), MHCII (clone 2G9), CD86 (clone GL1) (BD Biosciences, Germany), and CD23 (clone B3B4) (eBiosciences, Germany). Mitomycin-*c* was obtained from Sigma-Aldrich, Germany. CD19 MicroBeads isolation kit, CD5 Microbeads isolation kit, and regulatory T cells isolation kit were obtained from Miltenyi Biotec, Germany. Anti-mouse IL4 and anti-mouse IFNγ were from BD, Biosciences, Germany. TGFβ was purchased from R&D System, Germany. IL23 and IL6 were obtained from eBiosciences, Germany. Cytometric bead array (CBA) Mouse Th1/Th2/Th17 Cytokine Kit was obtained from BD, Biosciences, Germany.

Cell isolation and culture {#S2-3}
--------------------------

CD19^+^CD5^+^ B-1a B cells were magnetically isolated from PerC washouts of BALB/c or DBA/2J mated CBA/J pregnant females on day 14 of pregnancy. As control B-1a B cells were isolated from non-pregnant CBA/J females. Pure isolated B-1a B cells were treated with mitomycin-*c* and used as APCs. CD4^+^CD25^−^ naïve T cells were isolated from lymph nodes of non-pregnant C57BL/6 females. Isolated naïve T cells (2 × 10^5^) were cultured with mitomycin-*c* inactivated B-1a B cells (1 × 10^5^) (2:1) in 96-well round-bottom plates with 200 μl of RPMI medium supplemented with SFB (10%) and antibiotics for 5 days with or without the addition of a Th17 differentiation cytokines cocktail ([@B10]) composed of anti IFNγ (10 μg/ml), anti IL4 (10 μg/ml), TGFβ (3 ng/ml), IL6 (50 ng/ml), and IL23 (20 ng/ml). Supernatants were collected and frozen at −80°C.

Cell staining and flow cytometry {#S2-4}
--------------------------------

Peritoneal cavity cells were stained with specific antibodies or matched isotype controls for 30 min at 4°C. After washing, cells were analyzed with a FACSCalibur flow cytometer. Data were analyzed with FlowJo software (Tree Star Inc.). For analyzing the expression levels of MCHII, CD80, CD86, PD-L1, PD-L2, and FASL on CD19^+^CD23^−^CD5^+^ B-1a B cells mean fluorescence index (MFI) was applied using FlowJo software (Tree Star Inc.).

Cytokine detection in supernatants {#S2-5}
----------------------------------

Levels of IL17, TNFα, IFNγ, IL2, and IL6 cytokines were measured in supernatants by CBA Mouse Th1/Th2/Th17 Cytokine Kit and Th1/Th2 Inflammation Kit from BD Biosciences, following supplier recommendation. MCP1 was measured by using an ELISA kit from R&D System.

Statics {#S2-6}
-------

The statistical significance of comparisons of median values was assessed by the non-parametric Kruskal--Wallis test with GraphPad software.

Results {#S3}
=======

B-1a B cells from pregnant animals suffering pregnancy disturbances induce Th17 T cell differentiation while B-1a B cells from normal pregnant mice strongly inhibited it {#S3-7}
-------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Increasing evidence indicates that pregnancy disturbances, e.g., unexplained recurrent miscarriages ([@B8]) and pre-eclampsia ([@B11]) are associated with a prevalence of Th17 cells. B-1a B cells are potent inducers of Th17 cells differentiation ([@B15], [@B16], [@B21], [@B22]). Taking these into account we aimed to explore here the differential capacity of B-1a B cells from pregnant mice developing normal pregnancies or mice suffering from pregnancy disturbances to induce Th17 cell differentiation *in vitro*. Mitomycin-*c* treated B-1a B cells were co-cultured with allogeneic CD4^+^CD25^−^ naïve T cells and the production of IL17 was assayed in supernatants. In agreement with previous studies ([@B16]), B-1a B cells isolated from non-pregnant virgin control mice induced a slight production of IL17 by CD4^+^CD25^−^ naïve T cells (Figure [1](#F1){ref-type="fig"}A). This modest production of IL17 was lowered when T cells were cultured with B-1a B cells isolated from normal pregnant mice, although differences did not reach statistical significance (Figure [1](#F1){ref-type="fig"}A). Interestingly, when B-1a B cells isolated from animals suffering pregnancy disturbances were used to stimulate T cells, a significantly higher production of IL17 was observed as compared to T cells cultured with B-1a B cells from normal pregnant mice (Figure [1](#F1){ref-type="fig"}A). No differences were observed on IL17 production by T cells cultured with B-1a B cells from non-pregnant mice compared to T cells cultured with B-1a B cells from animal suffering from pregnancy disturbances (Figure [1](#F1){ref-type="fig"}A).

![**B-1a B cells from normal pregnant animals but not from pregnant animals suffering pregnancy disturbances inhibit Th17 T cell differentiation**. CD4^+^CD25^−^ naïve T cells (2 × 10^5^) were cultured with mitomycin-*c* treated CD19^+^CD5^+^ B-1a B cells (1 × 10^5^) (1:2) from non-pregnant, BALB/c mated (normal pregnant) or DBA/2J mated (developing pregnancy disturbances) CBA/J females without **(A)** or with **(B)** the addition of a Th17 cytokine differentiation cocktail. Levels of IL17 were assayed in supernatants. Data are expressed as Box and Whisker plots showing median. \**P* \< 0.05 as analyzed by the non-parametric Kruskal--Wallis test.](fimmu-05-00006-g001){#F1}

Differentiation of Th17 cells can be induced *in vitro* by exposing CD4^+^ T cells to optimal conditions of TGFβ, IL6, IL23, and blocking IFNγ and IL4 ([@B16]). We next wondered whether B-1a B cells from animals developing normal pregnancies not only fail to induce IL17 production by T cells as compared to B-1a B cells from animals suffering pregnancy disturbances but also can inhibit Th17 differentiation even under optimal conditions for Th17 development. We cultured CD4^+^CD25^−^ naïve T cells with B-1a B cells isolated from pregnant mice developing normal pregnancies with the addition of Th17 optimal condition cytokines. In addition, T cells were cultured with B-1a B cells from pregnant mice suffering pregnancy complications or from non-pregnant mice plus cytokines. As expected, when CD4^+^CD25^−^ naïve T cells were co-cultured with B-1a B cells isolated either from non-pregnant mice or pregnant mice developing pregnancy disturbances and cytokines were added, a potent induction of IL17 production by naïve T cells was observed (Figure [1](#F1){ref-type="fig"}B). Notably, the production of IL17 by T cells in these two groups was ≈10-fold higher as compared to the same groups without the addition of the Th17 stimulation cocktail (Figure [1](#F1){ref-type="fig"}A). This clearly confirms the robustness of the Th17 induction system. Remarkably, B-1a B cells isolated from pregnant mice developing normal pregnancies strongly inhibited the production of IL17 by CD4^+^CD25^−^ naïve T cells even under the addition of optimal cytokines conditions for Th17 cell development (Figure [1](#F1){ref-type="fig"}B). These results clearly demonstrate a differential capacity of B-1a B cells in the context of pregnancy: while B-1a B cells from animals developing pregnancy disturbances induce Th17 cells polarization, B-1a B cells from animals undergoing normal pregnancies manifested a strong inhibitory capacity.

B-1a B cells from pregnant animals suffering pregnancy disturbances but not from those developing normal pregnancies induced the production of Th1 cytokines by T cells {#S3-8}
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------

In addition to their capacity to induce Th17 differentiation, B-1a B cells were also shown to participate in the induction of Th1 polarization ([@B15]). We next wondered whether in the context of pregnancy, B-1a B cells might also have a differential role in inducing/inhibiting Th1 polarization. We observed that mitomycin*-c* treated B-1a B cells isolated from normal pregnant mice induced a lower but not significant production of Th1 pro-inflammatory cytokines, TNFα, IFNγ, IL2, and MCP1 by CD4^+^CD25^−^ naïve T cells as compared to B-1a B cells from non-pregnant control animals (Figures [2](#F2){ref-type="fig"}A--D). However, when T cells were cultured with B-1a B cells isolated from pregnant mice developing pregnancy disturbances, significantly higher levels of Th1 pro-inflammatory cytokines were observed as compared to T cells cultured with B-1a B cells isolated from normal pregnant mice (Figures [2](#F2){ref-type="fig"}A--D). No differences were observed on Th1 cytokines production by T cells cultured with B-1a B cells from non-pregnant mice compared to T cells cultured with B-1a B cells from animal suffering from pregnancy disturbances (Figures [2](#F2){ref-type="fig"}A--D). These results demonstrate that B-1a B cells from pregnant mice developing normal pregnancies induced a significantly lower production of Th1 cytokines by T cells as compared to B-1a B cells from animals suffering pregnancy disturbances.

![**B-1a B cells from pregnant animals developing pregnancy complications but not from those having normal pregnancies induce Th1 T cell polarization**. CD4^+^CD25^−^ naïve T cells (2 × 10^5^) were cultured with CD19^+^CD5^+^ B-1a B cells (1 × 10^5^) (2:1) from non-pregnant, BALB/c (normal pregnant) or DBA/2J (developing pregnancy disturbances) pregnant CBA/J females. Levels of TNFα **(A)**, IFNγ **(B)**, IL2 **(C)**, and MCP1 **(D)** Th1 cytokines were analyzed in supernatants. Data are expressed as Box and Whisker plots showing median. \**P* \< 0.05 as analyzed by the non-parametric Kruskal--Wallis test.](fimmu-05-00006-g002){#F2}

Levels of B-1a B cells in PerC do not change during pregnancy {#S3-9}
-------------------------------------------------------------

We next concentrated in the mechanisms behind the differential capacity of B-1a B cells from pregnant animals having normal pregnancies and those developing pregnancies disturbances in the regulation of Th1/17 T cell differentiation. We began analyzing the percentages of CD19^+^CD23^−^CD11b^+^CD5^+^ B-1a B cells ([@B23]) in the PerC of pregnant and non-pregnant mice. As displayed in Figure [3](#F3){ref-type="fig"} no differences were observed concerning the percentages of CD19^+^CD23^−^CD11b^+^CD5^+^ B-1a B cells in the PerC of pregnant animals having normal pregnancies compared to those suffering pregnancy disturbances and to non-pregnant controls. We have additionally analyzed the percentages of CD19^+^CD23^−^CD11b^+^CD5^−^B-1b cells as well as CD19^+^C23^+^ B2 B cells. Neither the percentages of B-1b cells (Figure [A1](#FA1){ref-type="fig"}A in Appendix) nor percentages of B2 B cells (data not showed) in PerC of non-pregnant as well as normal pregnant mice or animals suffering pregnancy disturbances were modified. These results suggest that the differential capacity of B-1a B cells from normal pregnant mice in inhibiting Th17/1 T cell differentiation compared to B-1a B cells from animal suffering pregnancy disturbances, is not related to changes in the levels of B-1a B cells.

![**Percentages of B-1a B cells do not change during pregnancy**. **(A)** Representative counter plots displaying the gating strategy used to analyze the percentages of CD19^+^CD23^−^CD11b^+^CD5^+^ B-1a B cells in the PerC of non-pregnant and pregnant mice. **(B)** Graph displays percentages of CD19^+^CD23^−^CD11b^+^CD5^+^ B-1a B cells in the PerC of non-pregnant as well as BALB/c (normal pregnant) and DBA/2J (pregnancy disturbances) pregnant CBA/J females. Data are expressed as Box and Whisker plots showing median. Differences were analyzed by the non-parametric Kruskal--Wallis test.](fimmu-05-00006-g003){#F3}

Pregnant animals developing normal pregnancies and animals suffering pregnancy disturbances have similar levels of MHCII expressing B-1a B cells {#S3-10}
------------------------------------------------------------------------------------------------------------------------------------------------

B cells present antigens to T cells in the context of MHCII molecule ([@B24], [@B25]). Having observed that percentages of B-1a B cells do not differ between animals having normal pregnancies compared to those developing pregnancy disturbances or to non-pregnant mice, we next analyzed the expression levels of MHCII molecule on CD19^+^CD23^−^CD5^+^ B-1a B cells as well as the percentages of MHCII expressing CD19^+^CD23^−^CD5^+^ B-1a B cells in non-pregnant as well as pregnant mice having normal pregnancies or developing pregnancies disturbances. Neither the expression levels of MHCII in CD19^+^CD23^−^CD5^+^ B-1a B (MFI: 2.7, 2.8, and 2.4, respectively) nor the percentages of MHCII expressing CD19^+^CD23^−^CD5^+^ B-1a B cells in PerC were modified among the groups (Figure [4](#F4){ref-type="fig"}). Similar results were observed when analyzing MHCII expression on CD19^+^CD23^−^CD5^−^B-1b cells (Figure [A1](#FA1){ref-type="fig"}B in Appendix)

![**B-1a B cells from pregnant animals developing normal pregnancies and animals suffering pregnancy disturbances display similar levels of MHCII expressing B-1a B cells**. **(A)** Representative contour and density plots displaying the gating strategy used to analyze the percentages of MHCII expressing CD19^+^CD23^−^CD5^+^ B-1a B cells in the PerC of non-pregnant and pregnant mice. **(B)** Graph depicts percentages of MHCII expressing CD19^+^CD23^−^CD5^+^ PerC B-1a B cells from non-pregnant as well as BALB/c (normal pregnant) and DBA/2J (pregnancy disturbances) pregnant CBA/J females. Data are expressed as Box and Whisker plots showing median. Differences were analyzed by the non-parametric Kruskal--Wallis test.](fimmu-05-00006-g004){#F4}

Percentages of CD86 expressing B-1a B cells are diminished during normal pregnancy {#S3-11}
----------------------------------------------------------------------------------

Activation and differentiation of naïve T cells upon antigen presentation require a proper interaction of CD28 expressed on T cells with co-stimulatory molecules (CD86 and CD80) expressed on APC ([@B26]--[@B28]). We observed similar levels of CD80 and CD86 expression on PerC CD19^+^CD23^−^CD5^+^ B-1a B cells from non-pregnant mice compared to pregnant mice developing normal, pregnancies or suffering pregnancy disturbances (CD80 MFI: 2.2, 2.2, and 2.5; CD86 MFI: 2.3, 2.1, and 2.4, respectively). However, percentages of CD86 expressing CD19^+^CD23^−^CD5^+^ B-1a B cells were significantly lower in PerC of pregnant mice developing normal pregnancies as compared to those suffering pregnancy disturbances or to non-pregnant control mice (Figure [5](#F5){ref-type="fig"}A). No differences were observed concerning percentages of CD80 expressing CD19^+^CD23^−^CD5^+^ B-1a B cells among the groups (Figure [5](#F5){ref-type="fig"}B). We have also analyzed the percentages of CD86 and CD80 expressing CD19^+^CD23^−^CD5^−^B-1b cells in PerC of non-pregnant as well as normal pregnant or pregnant mice suffering pregnancy disturbances and did not find any difference among the groups (Figure [A1](#FA1){ref-type="fig"}B in Appendix).

![**CD86 expressing B-1a B cells are diminished in pregnant mice developing normal pregnancies but not in those suffering pregnancy disturbances**. **(A)** Representative contour and density plots depicting gating strategy used to quantify percentages of CD86 expressing CD19^+^CD23^−^CD5^+^ PerC B-1a B cells of non-pregnant as well as BALB/c (normal pregnant) and DBA/2J (pregnancy disturbances) pregnant CBA/J females. Graph shows percentages of CD86 expressing CD19^+^CD23^−^CD5^+^ PerC B-1a B cells. **(B)** Representative contour and density plots depicting gating strategy used to quantify the percentages of CD80 expressing CD19^+^CD23^−^CD5^+^ PerC B-1a B cells of non-pregnant as well as BALB/c (normal pregnant) and DBA/2J (pregnancy disturbances) pregnant CBA/J females. Graph shows percentages of CD80 expressing CD19^+^CD23^−^CD5^+^ PerC B-1a B cells from non-pregnant as well as BALB/c or DBA/2J mated CBA/J females. Data are expressed as Box and Whisker plots showing median. \**P* \< 0.05 as analyzed by the non-parametric Kruskal--Wallis test.](fimmu-05-00006-g005){#F5}

We have additionally studied the expression levels of cellular markers (PD-L1, PD-L2, and FASL) on CD19^+^CD23^−^CD5^+^ B-1a B cells, all well known to take part in the interaction between B-1a and T cells. As for other cellular markers analyzed in this study we did not find any difference in the expression levels of PD-L1 (MFI: 318.5; 327 and 310, respectively), PD-L2 (MFI: 145, 138, and 141, respectively), and FASL (MFI: 36.70, 30.80, and 30.40, respectively) as well as in the percentages of PD-L1 (100% of B-1a B cells of all groups expressed PD-L1, data not showed), PD-L2 and FASL expressing CD19^+^CD23^−^CD5^+^ B-1a B cells between the groups (Figure [A2](#FA2){ref-type="fig"} in Appendix). These results suggest that the lower percentages of CD86 expressing B-1a B cells observed in normal pregnant animals may be one of the mechanisms as how these cells fails to induce Th1 and strongly inhibit Th17 T cell differentiation during normal pregnancy.

Discussion {#S4}
==========

The ability of B-1 B cells to induce the polarization of naïve T cells into pro-inflammatory Th17 and Th1 T cell subsets has been extensively demonstrated ([@B15], [@B16], [@B21], [@B22]). In this study we have confirmed and extended these results by showing that in the context of pregnancy B-1a B cells display a differential capacity in term of regulating pro-inflammatory T cell differentiation. B-1a B cells from pregnant mice developing normal pregnancies not only failed to induce Th17 differentiation but also showed to have a strong inhibitory capacity even in a favorable environment for the differentiation of Th17 cells. Notably, this inhibitory effect was not achieved when B-1a B cells were isolated from pregnant animals suffering pregnancy disturbances, clearly demonstrating a differential capacity of B-1a B cells from normal pregnant animals in controlling Th17 T cell differentiation.

Similarly, B-1a B cells from pregnant animals suffering pregnancy disturbances but not from animals developing normal pregnancies induced the production of pro-inflammatory Th1 cytokines by naïve T cells. These results suggest that during normal pregnancy B-1a B cells are turned into an transient state of tolerance that unable them to induce pro-inflammatory T cell activation and differentiation that can be deleterious for pregnancy to be maintained ([@B29]).

Activation of naïve T cells and posterior maturation into different T cell lineages is a multistep phenomenon requiring both, antigen-specific triggering of the T cell receptor complex and additional signaling via co-stimulatory molecules ([@B26], [@B27]). B cell antigen presentation to T cells occurs in the context of MHCII molecule and the interaction of CD28 receptor expressed on T cells with CD86 and CD80 ligands expressed on the B cells ([@B24], [@B28]). Blockage of CD28 and their ligands, CD86 ([@B30]) and CD80, has been shown to induce antigen-specific peripheral tolerance ([@B15]). In this regards, we showed a significant reduction in the percentages of CD86 expressing B-1a B cells in PerC of animals developing normal pregnancies as compared to non-pregnant mice and to pregnant mice suffering pregnancy disturbances. To note is the fact that despite the observed differences in the percentages of CD86 expressing B-1a B cells, the expression levels of CD86 in B-1a B cells, analyzed by MFI, was similar between the groups. Based on our results it is tempting to speculate that the reduction in the percentages of CD86 expressing B-1a B cells rather than down-regulation of CD86 itself on B-1a B cells, represents an adaptive mechanisms aimed to avoid undesired activation of pro-inflammatory T cells that can have a deleterious effect on pregnancy outcome. Interestingly, using the same animal model of pregnancy disturbance we used in this study, Jin and co-authors have showed that blocking CD86 with specific antibody, considerably improved pregnancy outcome in pregnant mice otherwise undergoing pregnancy disturbances ([@B30], [@B31]). In addition, Wang and Rothstein using either a CD86 neutralizing antibody or B-1a B cells isolated from CD86 KO animals have recently showed that the lack of CD86 expression on B-1a B cells is linked to their incapacity to induce Th17 differentiation ([@B16]). In keeping with our results, Zhong and co-authors have nicely demonstrated that the ability of B-1a B cells to stimulate alloreactive T cells can be inhibited by blocking CD86 expression on B-1a B cells, rather under this condition, B-1a B cells favor the development of inducible FOXP3 newly expressing regulatory T cells (iTregs) ([@B15]).

In conclusion, we have demonstrated in this study that B-1a B cells manifest a differential capability in terms of regulating pro-inflammatory T cell activation and differentiation during pregnancy. Besides, we provided evidences that this differential capacity may be associated with the levels of CD86 expressing B-1a B cells.

Overall, we provided evidences highlighting the central role of B-1a B cells in controlling pro-inflammatory T cell activation and polarization in the context of pregnancy. This opens a new avenue for exploring strategies to control undesired immune activation that may compromise pregnancy outcome.
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![**Percentages of B-1b cells as well as percentages of MHCII, CD86, and CD80 expressing B-1b cells are similar in normal pregnant mice and in pregnant mice suffering pregnancy disturbances**. **(A)** Graph showing no differences in PerC CD19^+^CD23^−^CD11b^+^CD5^−^B-1b cells percentages between non-pregnant and normal pregnant mice or pregnant mice suffering pregnancy disturbances. **(B)** Percentages of MHCII, CD80, and CD86 expressing PerC CD19^+^CD23^−^CD5^−^B-1b cells are similar among the groups.](fimmu-05-00006-a001){#FA1}

![**Levels of FASL and PD-L2 expressing B-1a B cells are not affected in normal as well as disturbed pregnancies**. Levels of FASL **(A)** and PD-L2 **(B)** expressing CD19^+^CD23^−^CD5^+^ PerC B-1a B cells are similar between non-pregnant and pregnant mice.](fimmu-05-00006-a002){#FA2}
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